Morten Herholdt
Stock Analyst at HSBC
(1.04)
# 3,962
Out of 5,238 analysts
16
Total ratings
36.36%
Success rate
-8.79%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $265 → $280 | $221.32 | +26.51% | 3 | Mar 17, 2026 | |
| LH Labcorp Holdings | Upgrades: Buy | n/a | $254.12 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $82.83 | +171.64% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $193.45 | +76.79% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $131.33 | -47.46% | 2 | Apr 24, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $379.98 | +42.11% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $71.86 | -27.64% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $178.71 | +45.49% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $331.70 | -3.53% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $1.31 | +785.50% | 1 | Sep 6, 2023 |
Johnson & Johnson
Mar 17, 2026
Maintains: Buy
Price Target: $265 → $280
Current: $221.32
Upside: +26.51%
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $254.12
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $82.83
Upside: +171.64%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $193.45
Upside: +76.79%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $131.33
Upside: -47.46%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $379.98
Upside: +42.11%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $71.86
Upside: -27.64%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $178.71
Upside: +45.49%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $331.70
Upside: -3.53%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.31
Upside: +785.50%